Tumambiling, Aisa A.

HRN: 27-00-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2025
CEFUROXIME 750MG (VIAL)
11/11/2025
11/18/2025
IV
750 Mg
Q8HRS
Acute Calculous Cholelithiasis

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Non-compliant To Guidelines